학술논문
A phase 1 evaluation of the safety and tolerability of niraparib in combination with everolimus in advanced ovarian and breast cancers
Document Type
Article
Author
Source
In: Cancer Medicine . (Cancer Medicine, September 2023, 12(18):18654-18665)
Subject
Language
English
ISSN
20457634